Evolus (NASDAQ: EOLS) reported Q3 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $69 million versus the consensus estimate of $67.69 million.

GUIDANCE:

Evolus sees FY2025 revenue of $295-305 million, versus the consensus of $296 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.